Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001972155 | SCV002207539 | uncertain significance | not provided | 2021-07-17 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This variant has not been reported in the literature in individuals affected with SPART-related conditions. This variant is present in population databases (rs766063946, ExAC 0.03%). This sequence change replaces valine with glycine at codon 251 of the SPART protein (p.Val251Gly). The valine residue is highly conserved and there is a moderate physicochemical difference between valine and glycine. |